Business Context and Reporting Period
This Form 8-K was filed by Trovagene, Inc. on November 2, 2016. The filing serves as a current report to announce the scheduled release of financial results for the third quarter ended September 30, 2016.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural announcement regarding the timing of a future earnings release rather than a financial statement.
Material Changes
No material changes to financial performance or operations are detailed in this filing. The only reported event is the scheduling of the third-quarter 2016 earnings announcement.
Guidance, Outlook, and Management Commentary
Management has announced that financial results for the third quarter ended September 30, 2016, will be reported on Wednesday, November 9, 2016, at 4:00 p.m. Eastern Standard Time (1:00 p.m. Pacific Standard Time). No specific guidance, risk factors, or unusual items are disclosed in this text.
Investor Verification Checklist
- Verify the actual financial results released on November 9, 2016, as this filing only announces the date.
- Review the press release furnished as Exhibit 99.1 for any additional context not included in the 8-K summary.
- Confirm the company name is Trovagene, Inc., noting the input metadata referenced "Cardiff Oncology, Inc." which appears to be a discrepancy in the request metadata versus the filing content.